Divergent effects of nitric oxide donors on the biliary efflux transporters in isolated perfused rat livers: Nitric oxide-independent inhibition of ABC transporters by sodium nitroprusside

Drug Metabolism Letters

Volumn 5, Issue 1, 2011, Pages 64-72

  Parasrampuria, Ridhi ^a   Mehvar, Reza ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

5 (and 6) carboxy 2 ,7 dichlorofluorescein; Efflux transporters; Isolated perfused rat liver; Multidrug resistance related protein type 2; Nitric oxide; P glycoprotein; Rhodamine 123; Rhodamine glucuronide

Indexed keywords

ADENOSINE TRIPHOSPHATE; DICHLOROFLUORESCEIN; DRUG METABOLITE; GLYCOPROTEIN P; ISOSORBIDE DINITRATE; MULTIDRUG RESISTANCE PROTEIN 2; NITROPRUSSIDE SODIUM; RHODAMINE 123;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; DRUG MECHANISM; EXCRETION; HEPATOBILIARY SYSTEM; LIVER; LIVER PERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TRANSPORT; RAT; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BILE; BIOLOGICAL TRANSPORT; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCEINS; GLUCURONIDES; ISOSORBIDE DINITRATE; KINETICS; LIVER; MALE; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROPRUSSIDE; P-GLYCOPROTEIN; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY; RHODAMINE 123;

RATTUS;

EID: 79551628502     PISSN: 18723128     EISSN: None     Source Type: Journal    
DOI: 10.2174/187231211794455244     Document Type: Article

References (39)

1. Moncada, S.; Palmer, R. M.; Higgs, E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 1991, 43, 109-142.
2. Morgan, E. T.; Goralski, K. B.; Piquette-Miller, M.; Renton, K. W.; Robertson, G. R.; Chaluvadi, M. R.; Charles, K. A.; Clarke, S. J.; Kacevska, M.; Liddle, C.; Richardson, T. A.; Sharma, R.; Sinal, C. J. Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer. Drug Metab. Dispos., 2008, 36, 205-216.
3. Vos, T. A.; Gouw, A. S.; Klok, P. A.; Havinga, R.; van Goor, H.; Huitema, S.; Roelofsen, H.; Kuipers, F.; Jansen, P. L.; Moshage, H. Differential effects of nitric oxide synthase inhibitors on endotoxininduced liver damage in rats. Gastroenterology, 1997, 113, 1323-1333.
4. Wei, C. L.; Khoo, H. E.; Lee, K. H.; Hon, W. M. Differential expression and localization of nitric oxide synthases in cirrhotic livers of bile duct-ligated rats. Nitric Oxide, 2002, 7, 91-102.
5. Vuppugalla, R.; Mehvar, R. Hepatic disposition and effects of nitric oxide donors: rapid and concentration-dependent reduction in the cytochrome P450-mediated drug metabolism in isolated perfused rat livers. J. Pharmacol. Exp. Ther., 2004, 310, 718-727.
6. Vuppugalla, R.; Mehvar, R. Short-term inhibitory effects of nitric oxide on cytochrome P450-mediated drug metabolism: time dependency and reversibility profiles in isolated perfused rat livers. Drug Metab. Dispos., 2004, 32, 1446-1454.
7. Vuppugalla, R.; Mehvar, R. Enzyme-selective effects of nitric oxide on affinity and maximum velocity of various rat cytochromes P450. Drug Metab. Dispos., 2005, 33, 829-836.
8. Vuppugalla, R.; Mehvar, R. Selective effects of nitric oxide on the disposition of chlorzoxazone and dextromethorphan in isolated perfused rat livers. Drug Metab. Dispos., 2006, 34, 1160-1166.
9. Morgan, E. T.; Ullrich, V.; Daiber, A.; Schmidt, P.; Takaya, N.; Shoun, H.; McGiff, J. C.; Oyekan, A.; Hanke, C. J.; Campbell, W. B.; Park, C. S.; Kang, J. S.; Yi, H. G.; Cha, Y. N.; Mansuy, D.; Boucher, J. L. Cytochromes P450 and flavin monooxygenases-- targets and sources of nitric oxide. Drug Metab. Dispos., 2001, 29, 1366-1376.
10. Morgan, E. T.; Li Masters, T.; Cheng, P. Y. Mechanisms of cytochrome P450 regulation by inflammatory mediators. Toxicology, 2002, 181, 207-210.
11. Renton, K. W. Cytochrome p450 regulation and drug biotransformation during inflammation and infection. Curr. Drug Metab., 2004, 5, 235-243.
12. Morgan, E. T. Regulation of cytochromes P450 during inflammation and infection. Drug Metab. Rev., 1997, 29, 1129-1188.
13. De Paepe, P.; Belpaire, F. M.; Buylaert, W. A. Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock. Clin. Pharmacokinet., 2002, 41, 1135-1151.
14. Toft, P.; Heslet, L.; Hansen, M.; Klitgaard, N. A. Theophylline and ethylenediamine pharmacokinetics following administration of aminophylline to septic patients with multiorgan failure. Intensive Care Med., 1991, 17, 465-468.
15. Carcillo, J. A.; Doughty, L.; Kofos, D.; Frye, R. F.; Kaplan, S. S.; Sasser, H.; Burckart, G. J. Cytochrome P450 mediated-drug metabolism is reduced in children with sepsis-induced multiple organ failure. Intensive Care Med., 2003, 29, 980-984.
16. Shitara, Y.; Horie, T.; Sugiyama, Y. Transporters as a determinant of drug clearance and tissue distribution. Eur. J. Pharm. Sci., 2006, 27, 425-446.
17. Aoki, K.; Nakajima, M.; Hoshi, Y.; Saso, N.; Kato, S.; Sugiyama, Y.; Sato, H. Effect of aminoguanidine on lipopolysaccharideinduced changes in rat liver transporters and transcription factors. Biol. Pharm. Bull., 2008, 31, 412-420.
18. Aoki, K.; Saso, N.; Kato, S.; Sugiyama, Y.; Sato, H. Nitric oxide and peroxynitrite regulate transporter transcription in rat liver slices. Biol. Pharm. Bull., 2008, 31, 1882-1887.
19. Cha, S.; Kim, H.; Jung, N.; Lee, W.; Kim, J.; Cha, Y. Downregulation of organic anion transporter 2 mRNA expression by nitric oxide in primary cultured rat hepatocytes. IUBMB Life, 2002, 54, 129-135.
20. Elferink, M. G.; Olinga, P.; Draaisma, A. L.; Merema, M. T.; Faber, K. N.; Slooff, M. J.; Meijer, D. K.; Groothuis, G. M. LPSinduced down-regulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. Am. J. Physiol. Gastrointest. Liver Physiol., 2004, 287, G1008-1016.
21. Song, I. S.; Lee, I. K.; Chung, S. J.; Kim, S. G.; Lee, M. G.; Shim, C. K. Effect of nitric oxide on the sinusoidal uptake of organic cations and anions by isolated hepatocytes. Arch. Pharm. Res., 2002, 25, 984-988.
22. Fardel, O.; Le Vee, M. Regulation of human hepatic drug transporter expression by pro-inflammatory cytokines. Expert Opin. Drug Metab. Toxicol., 2009, 5, 1469-1481.
23. Sukhai, M.; Yong, A.; Pak, A.; Piquette-Miller, M. Decreased expression of P-glycoprotein in interleukin-1 beta and interleukin-6 treated rat hepatocytes. Inflamm. Res., 2001, 50, 362-370.
24. Cherrington, N. J.; Slitt, A. L.; Li, N.; Klaassen, C. D. Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats. Drug Metab Dispos, 2004, 32, 734-741.
25. Hoffmann, U.; Kroemer, H. K. The ABC transporters MDR1 and MRP2: multiple functions in disposition of xenobiotics and drug resistance. Drug Metab. Rev., 2004, 36, 669-701.
26. Parasrampuria, R.; Mehvar, R. Effects of P-glycoprotein and Mrp2 inhibitors on the hepatobiliary disposition of Rhodamine 123 and its glucuronidated metabolite in isolated perfused rat livers. J. Pharm. Sci., 2010, 99, 455-466.
27. Wang, Y.; Hao, D.; Stein, W. D.; Yang, L. A kinetic study of Rhodamine123 pumping by P-glycoprotein. Biochim. Biophys. Acta, 2006, 1758, 1671-1676.
28. Zamek-Gliszczynski, M. J.; Xiong, H.; Patel, N. J.; Turncliff, R. Z.; Pollack, G. M.; Brouwer, K. L. Pharmacokinetics of 5 (and 6)- carboxy-2',7'-dichlorofluorescein and its diacetate promoiety in the liver. J. Pharmacol. Exp. Ther., 2003, 304, 801-809.
29. Chandra, P.; Johnson, B. M.; Zhang, P.; Pollack, G. M.; Brouwer, K. L. Modulation of hepatic canalicular or basolateral transport alters hepatobiliary disposition of a model organic anion in the isolated perfused rat liver. Drug Metab. Dispos., 2005, 33, 1238-1243.
30. Feelisch, M. The use of nitric oxide donors in pharmacological studies. Naunyn Schmiedebergs Arch. Pharmacol., 1998, 358, 113-122.
31. Minamiyama, Y.; Takemura, S.; Imaoka, S.; Funae, Y.; Tanimoto, Y.; Inoue, M. Irreversible inhibition of cytochrome P450 by nitric oxide. J. Pharmacol. Exp. Ther., 1997, 283, 1479-1485.
32. Smith, S.; Huang, W.; Chancy, C.; Ganapathy, V. Regulation of the reduced-folate transporter by nitric oxide in cultured human retinal pigment epithelial cells. Biochem. Biophys. Res. Commun., 1999, 257, 279-283.
33. Mehvar, R.; Zhang, X. P. Development and application of an isolated perfused rat liver model to study the stimulation and inhibition of tumor necrosis factor-alpha production ex vivo. Pharm. Res., 2002, 19, 47-53.
34. Arnold, W. P.; Longnecker, D. E.; Epstein, R. M. Photodegradation of sodium nitroprusside: biologic activity and cyanide release. Anesthesiology, 1984, 61, 254-260.
35. Parasrampuria, R.; Mehvar, R. Hepatobiliary disposition of rhodamine 123 in isolated perfused rat livers. Xenobiotica, 2008, 38, 1263-1273.
36. Manfredi, G.; Yang, L.; Gajewski, C. D.; Mattiazzi, M. Measurements of ATP in mammalian cells. Methods, 2002, 26, 317-326.
37. Gores, G. J.; Nieminen, A. L.; Wray, B. E.; Herman, B.; Lemasters, J. J. Intracellular pH during "chemical hypoxia" in cultured rat hepatocytes. Protection by intracellular acidosis against the onset of cell death. J. Clin. Invest., 1989, 83, 386-396.
38. Johnson, L. V.; Walsh, M. L.; Bockus, B. J.; Chen, L. B. Monitoring of relative mitochondrial membrane potential in living cells by fluorescence microscopy. J. Cell. Biol., 1981, 88, 526-535.
39. Ros, J. E.; Roskams, T. A.; Geuken, M.; Havinga, R.; Splinter, P. L.; Petersen, B. E.; LaRusso, N. F.; van der Kolk, D. M.; Kuipers, F.; Faber, K. N.; Muller, M.; Jansen, P. L. ATP binding cassette transporter gene expression in rat liver progenitor cells. Gut, 2003, 52, 1060-1067.